Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Healthcare (Basel, Switzerland)|December 11, 2025
Palliative Care in Shanghai Communities: Needs, Influencing Factors and Preferences Among Older Adults with Chronic DiseasesJiameng Li, Jiangjiang He, Zhenqing Tang, et al.
Bioscience Trends|June 17, 2026
Clinical translation and accessibility of brain-computer interfaces: From technology development to clinical applicationHui Sun, Ru Wang, Kenji Karako, et al.
Intractable & Rare Diseases Research|September 1, 2021
The usage of enzyme replacement treatments, economic burden, and quality of life of patients with four lysosomal storage diseases in Shanghai, ChinaJiahao Hu, Lin Zhu, Jiangjiang He, et al.
Intractable & Rare Diseases Research|December 4, 2024
Protecting the socioeconomic rights and interests of patients with rare diseases based on an innovative payment mechanismAmei He, Minxing Chen, Peipei Song, et al.
BMC Health Services Research|November 23, 2020
The impacts and unintended consequences of the nationwide pricing reform for drugs and medical services in the urban public hospitals in ChinaXiaoxi Zhang, Hongyu Lai, Lidan Zhang, et al.
Intractable & Rare Diseases Research|June 21, 2019
Accessibility of drugs for rare diseases in China: Policies and current situationYan Yang, Qi Kang, Jiahao Hu, et al.
Bioscience Trends|May 12, 2020
Introduction on collective quarantine of close contacts of patients with COVID-19 for medical observation in China: from the perspective of frontline staffChenjie Dong, Yuan Tian, Wenzhong Xu, et al.
Intractable & Rare Diseases Research|November 29, 2023
Release and impact of China's "Second List of Rare Diseases"Mi Tang, Yan Yang, Ziping Ye, et al.
Bioscience Trends|November 27, 2018
China issues the National Essential Medicines List (2018 edition): Background, differences from previous editions, and potential issuesJiangjiang He, Mi Tang, Ziping Ye, et al.
Drug Discoveries & Therapeutics|June 16, 2020
Prospects for development of group purchasing organizations (GPOs) in China within the context of national centralized drug procurementMinxing Chen, Lixuan Cong, Jiangjiang He, et al.
Pageof 4